Breast reconstruction with implants, tissue expanders and AlloDerm: predicting volume and maximizing the skin envelope in skin sparing mastectomies

The Breast Journal
Nicholas Haddock, Jamie Levine

Abstract

AlloDerm has been used as a tissue supplement in conjunction with the pectoralis major muscle to provide full coverage over an implant in breast reconstruction. While this method of reconstruction has shown promising results there is little known on the relationship of AlloDerm size and potential immediate expansion volume. A retrospective chart review was completed evaluating all tissue expander or primary implant reconstructions using AlloDerm. Data recorded included: The type/size of implant/expander, dimensions of the AlloDerm used, initial fill volume, number of expansions and time period of expansion. Statistical analysis was completed with a linear regression model. AlloDerm was used on 49 patients (72 reconstructions). Thirty-four patients (50 reconstructions) underwent reconstruction with a tissue expander and 15 patients (22 reconstructions) underwent a single stage reconstruction with a permanent implant. The tissue expander volume filled (cc) could be predicted by 5 x surface area of AlloDerm (cm(2)) - 12 (R(2) = 0.62) and 80 x height of AlloDerm (cm) - 15 (R(2) = 0.59). The tissue expanders could be filled to an average of 75% of total size and required three to four injections in the postoperative period to reach ...Continue Reading

References

Dec 1, 1968·Plastic and Reconstructive Surgery·W C Dempsey, W D Latham
Apr 1, 1984·Plastic and Reconstructive Surgery·L A StevensK A Forde
Jul 1, 1984·Annals of Plastic Surgery·P GoldbergH M Goldberg
Feb 1, 1982·Plastic and Reconstructive Surgery·C Radovan
Mar 1, 1981·Plastic and Reconstructive Surgery·R P GruberD R Laub
Mar 16, 2000·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·S K Al-GhazalR W Blamey
Feb 15, 2001·Plastic and Reconstructive Surgery·S L Spear, C J Spittler
Aug 10, 2001·Plastic and Reconstructive Surgery·R V Dowden
Oct 28, 2003·Plastic and Reconstructive Surgery·Richard A Baxter
Jul 6, 2004·The Journal of Surgical Research·Flavio G Rocha, Edward E Whang
Aug 18, 2005·Annals of Plastic Surgery·Karl H Breuing, Stephen M Warren
Dec 24, 2005·Annals of Plastic Surgery·G Mabel Gamboa-Bobadilla
Apr 27, 2007·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Vijay BindingnaveleDong-Joon Lee
Jul 17, 2007·Plastic and Reconstructive Surgery·Richard J Zienowicz, Ercan Karacaoglu
Aug 28, 2007·Annals of Plastic Surgery·Karl H Breuing, Amy S Colwell
Sep 28, 2007·Breast Cancer Research and Treatment·Kari HemminkiJusto Lorenzo Bermejo
Jan 1, 2001·Aesthetic Surgery Journal·D I Duncan

❮ Previous
Next ❯

Citations

Mar 3, 2011·Plastic and Reconstructive Surgery·Melissa A CrosbySteven J Kronowitz
Nov 1, 2012·Plastic and Reconstructive Surgery·Scott L SpearAli Al-Attar
Mar 23, 2011·World Journal of Surgical Oncology·Shirley A CrenshawJeffery K Chapman
Mar 13, 2012·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Kyle J CheplaHooman T Soltanian
Mar 11, 2011·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·T JoAnna NguyenAlex K Wong
Aug 27, 2013·Annals of Surgical Oncology·Eric C BurdgeV Suzanne Klimberg
Aug 25, 2015·Plastic and Reconstructive Surgery. Global Open·Georgia C YalanisJustin M Sacks
Nov 30, 2020·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Anna LuanRahim S Nazerali

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.